111 logo

111(NASDAQ) YI

Market Cap$17.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-98%
5 Year-95%
1 Year-28%
1 Month-0%
$3.25
-1.66%
-0.05Today
111 last closing stock price
MetricPriceDate
Last closeUSD 3.312026-10-01
111 stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.94%USD 3.592026-09-24
1 month-0.45%USD 3.322026-09-01
3 month-19.98%USD 4.132026-07-02
Year to date+29.1%USD 2.562025-12-31
1 year-28.15%USD 4.602025-10-01
3 year-87.29%USD 26.002023-10-02
5 year-94.59%USD 61.102021-10-01
Since inception-97.61%USD 138.002018-09-12

111 Financials at a Glance

Market Cap

$17.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥10.44B

Net Income (TTM)

-CN¥95.03M

EPS (TTM)

-$1.73

P/E Ratio

-1.91

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$3.25

Volume

11,195.596

Open

$3.26

Previous Close

$3.31

Daily Range

$3.21 - $3.57

52-Week Range

$2.48 - $11.17

Estimated Earnings Date

Nov 26, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 111

111, Inc. is a leading player in the Chinese healthcare sector, established in 2010 and based in Shanghai. The company operates a comprehensive online-to-offline (O2O) ecosystem, facilitating the sale of a wide range of medical and wellness products through both B2B and B2C channels.

Products and Services
  • Prescription medications and over-the-counter drugs
  • Dietary supplements and personal care items
  • Online consultation and electronic prescription fulfillment
Growth Outlook
  • Revenue increased to CNY 2.36 billion in Q1 2026
  • Gross profit margin improved to 5.33% in Q1 2026
  • Strong online marketplace growth supports future expansion
Financial Highlights
  • Net income of CNY -37.04 million in Q1 2026
  • Operating cash flow of CNY -91.72 million in Q1 2026
  • Current ratio of 1.08 indicates stable liquidity
111, Inc. has established a robust operational framework that includes warehousing, logistics management, and IT support. The company caters to a diverse clientele, including individual consumers, pharmacies, and medical practitioners. Recent financial performance shows a revenue of CNY 2.36 billion for Q1 2026, reflecting a solid market presence. Despite a net loss of CNY 37.04 million, the company maintains a current ratio of 1.08, indicating adequate liquidity to meet short-term obligations. The growth in revenue and improvements in gross profit margin suggest potential for future profitability. The online marketplace continues to expand, positioning 111, Inc. favorably within the evolving healthcare landscape in China.
AI Generated • Sep 17, 2026

Industry

Food and Staples Retailing

Employees

1,063

CEO

Jun Ling Liu, MBA

Headquarters

Shanghai, SH 201203, CN

YI Financials

Key Financial Metrics (TTM)

Gross Margin

5.73%

Operating Margin

-0.48%

Net Income Margin

-0.91%

Return on Equity

23.64%

Return on Capital

N/A

Return on Assets

-5.31%

Earnings Yield

-52.36%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.19M

Volume

11.20K

Avg. Volume

11.69K

Financials (TTM)

Gross Profit

CN¥598.89M

Operating Income

-CN¥50.15M

EBITDA

-CN¥40.75M

Operating Cash Flow

-CN¥35.21M

Capital Expenditure

-CN¥4.45M

Free Cash Flow

-CN¥39.66M

Cash & ST Invst.

CN¥381.26M

Total Debt

CN¥281.98M

111 Performance Analysis

111 annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 2,007,316,9274.2%
20232023-12-31CNY 2,109,819,1485.1%
20242024-12-31CNY 2,001,057,949-5.2%
20252025-12-31CNY 1,746,694,543-12.7%
111 sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-6.4%
Q42025-12-31-7.3%
Q12026-03-31-15.1%
Q22026-06-30-2.6%
111 annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY -7.43-40.7%
20232023-12-31CNY -6.57-11.5%
20242024-12-31CNY -1.05-84.1%
20252025-12-31CNY -1.061.4%
111 sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3033.0%
Q42025-12-31-21.3%
Q12026-03-31-130.8%
Q22026-06-30-4.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥2.30B

-28.3%

Gross Profit

CN¥132.27M

-28.6%

Gross Margin

5.75%

N/A

Market Cap

$17.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$16.12K

N/A

Employees

1,063

N/A

Net Income

-CN¥39.13M

-100.2%

EBITDA

-CN¥22.77M

-2013.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥381.26M

-14.8%

Total Debt

CN¥281.98M

+32.4%

Accounts Receivable

CN¥257.91M

-24.8%

Inventory

CN¥132.16M

-89.7%

Long Term Debt

CN¥21.99M

-48.8%

Short Term Debt

CN¥260.00M

+52.9%

Return on Assets

-5.31%

N/A

Return on Invested Capital

-27.30%

N/A

Free Cash Flow

-CN¥11.44M

+81.4%

Operating Cash Flow

-CN¥11.44M

+81.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DYAIDyadic International, Inc.
$0.46+7.08%
RNTXRein Therapeutics Inc.
$0.81-4.81%
NMTCNeuroOne Medical Technologies Corporation
$1.15+16.23%
ELUTElutia Inc
$0.81+1.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NKENike
$33.16-5.66%
NVDANvidia
$235.28+1.92%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$29.32-7.67%
SPCXSpace Exploration Technologies
$157.76+6.54%

Questions About YI

What is the current price of 111?

111 is trading at $3.25 per share.

What is the 52-week range for 111?

Over the past 52 weeks, 111 has traded between $2.48 and $11.17.

How much debt does 111 have?

As of the most recent reporting period, 111 reported total debt of CN¥41.56M.

How much cash does 111 have on hand?

111 reported CN¥47.32M in cash and cash equivalents in its most recent financial results.

What is 111’s dividend yield?

111 does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.